EUVIMEDEUVIMED entdecken
Crossref

Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder

Vicent Llorca-Bofí, Miquel Bioque, Santiago Madero, Andrea Mallorquí, Cristina Oliveira, Marina Garriga, Eduard Parellada, Clemente García-Rizo

Pharmacopsychiatry · 01.07.2024 · 57 (04) · 173-179

DOI: 10.1055/a-2290-6386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacopsychiatry, erschienen am 01.07.2024. Verfasst von Vicent Llorca-Bofí und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Clozapine, Antipsychotic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clozapine is the recommended treatment for managing treatment-resistant schizophrenia (TRS), and immunological mechanisms may be involved in its unique antipsychotic efficacy. This study investigated whether baseline immune abnormalities measured with blood cell count ratios can predict the clinical response after initiating treatment with clozapine in patients with clozapine naïve TRS.

Methods

A longitudinal design was developed, involving 32 patients diagnosed with treatment-resistant, clozapine-naïve schizophrenia-spectrum disorder. Patients were evaluated at baseline before clozapine starting and 8 weeks of follow-up. Psychopathological status and immune abnormalities (blood cell count ratios: neutrophil-lymphocyte ratio [NLR], monocyte-lymphocyte ratio [MLR], platelet-lymphocyte ratio [PLR] and basophil-lymphocyte ratio [BLR]) were evaluated in each visit.

Results

Baseline NLR (b=− 0.364; p=0.041) and MLR (b =− 0.400; p=0.023) predicted the change in positive symptoms over the 8-week period. Patients who exhibited a clinical response showed higher baseline NLR (2.38±0.96 vs. 1.75±0.83; p=0.040) and MLR (0.21±0.06 vs. 0.17±0.02; p=0.044) compared to non-responders. In the ROC analysis, the threshold points to distinguish between responders and non-responders were approximately 1.62 for NLR and 0.144 for MLR, yielding AUC values of 0.714 and 0.712, respectively. No statistically significant differences were observed in the blood cell count ratios from baseline to the 8-week follow-up.

Conclusion

Our study emphasizes the potential clinical significance of baseline NLR and MLR levels as predictors of initial clozapine treatment response in patients with TRS. Future studies with larger sample sizes and longer follow-up periods should replicate our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineAntipsychotic AgentsHumansMaleFemaleAdultBlood Cell CountLongitudinal StudiesSchizophrenia, Treatment-ResistantMiddle AgedTreatment OutcomeSchizophreniaYoung Adult

Substanzen

ClozapineAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • University of Coimbra, Coimbra, Portugal.
  • Bipolar and Depressive Disorders Unit, Neurosciences Institute, Hospital Clínic Barcelona, Barcelona, Spain.

Zitieren

APA

Llorca-Bofí, V., Bioque, M., Madero, S., Mallorquí, A., Oliveira, C., Garriga, M., Parellada, E., & García-Rizo, C. (2024). Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder. Pharmacopsychiatry, 57(04), 173-179. https://doi.org/10.1055/a-2290-6386

Vancouver

Llorca-Bofí V, Bioque M, Madero S, Mallorquí A, Oliveira C, Garriga M, et al. Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder. Pharmacopsychiatry. 2024;57(04):173-179. doi:10.1055/a-2290-6386

BibTeX
@article{LlorcaBof2024,
  author = {Llorca-Bofí, Vicent and Bioque, Miquel and Madero, Santiago and Mallorquí, Andrea and Oliveira, Cristina and Garriga, Marina and Parellada, Eduard and García-Rizo, Clemente},
  title = {Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder},
  journal = {Pharmacopsychiatry},
  year = {2024},
  volume = {57},
  number = {04},
  pages = {173--179},
  doi = {10.1055/a-2290-6386}
}
Kostenlos starten →